DOCSLIB.ORG

Peak Flow Measure: an Index of Respiratory Function?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Peak Flow Measure: An Index of Respiratory Function? D. Devadiga, Aiswarya Liz Varghese, J. Bhat, P. Baliga, J. Pahwa Department of Audiology and Speech Language Pathology, Kasturba Medical College (A Unit of Manipal University), Mangalore -575001 Corresponding Author: Aiswarya Liz Varghese Received: 06/12/2014 Revised: 26/12/2014 Accepted: 05/01/2015 ABSTRACT Aerodynamic analysis is interpreted as a reflection of the valving activity of the larynx. It involves measuring changes in air volume, flow and pressure which indicate respiratory function. These measures help in determining the important aspects of lung function. Peak expiratory flow rate is a widely used respiratory measure and is an effective measure of effort dependent airflow. Aim: The aim of the current study was to study the peak flow as an aerodynamic measure in healthy normal individuals Method: The study group was divided into two groups with n= 60(30 males and 30 females) in the age range of 18-22 years. The peak flow was measured using Aerophone II (Voice Function Analyser). The anthropometric measurements such as height, weight and Body Mass Index was calculated for all the participants. Results: The peak airflow was higher in females as compared to that of males. It was also observed that the peak air flow rate was correlating well with height and weight in males. Conclusions: Speech language pathologist should consider peak expiratory airflow, a short sharp exhalation rate as a part of routine aerodynamic evaluation which is easier as compared to the otherwise commonly used measure, the vital capacity. Key words: Peak expiratory flow rate, Height, Weight, Body mass Index, peak flow meter INTRODUCTION respiratory measure and is an effective Owing to the technological measure of effort dependent airflow. It is the advancement over the past 30 years, the most commonly used to monitor the lung respiratory function testing has gained function. [‎1] Peak expiratory flow rate can be momentum as a clinical measure and is defined as the highest flow rate sustained by presently considered as an essential an individual for at least ten seconds. [‎2] prerequisite to diagnose various obstructive Spirometry is the widely used and restrictive disorders of the respiratory screening test for lung function. Invariably, system. the measurement of peak expiratory air flow Respiratory function is measured by is generally carried out using sophisticated aerodynamic analysis of voice. This spirometer using forced vital capacity measurement involves changes with respect maneuver in clinical setup. At home, the to the air volume, airflow and air pressure. participants with chronic air flow Peak Expiratory Flow Rate is a widely used obstruction who carry out their Peak International Journal of Health Sciences & Research (www.ijhsr.org) 240 Vol.5; Issue: 2; February 2015 expiratory air flow measurement usually do glottal aerodynamic input power, acoustic so by using peak flow meters. The peak flow output power and glottal efficiency), and meter is one of the means of objectively velocity of articulation (registration of assessing and monitoring the airway adduction, Abduction rate of the glottis, function. A peak flow meter is a small hand- tongue or the velum as movements per held device that measures how fast a person second). can blow air out of the lungs when there is The peak expiratory flow rate forceful exhalation, after maximum basically provides information regarding the inhalation. The peak flow meter helps to force of the contraction of the expiratory assess the airflow through the airways and muscles of respiration. Peak expiratory flow thus helps to determine the degree of rate has been well correlated to maximum obstruction along them. expiratory pressure which is a representation The measurement of peak expiratory of respiratory muscle strength. [‎3] The higher flow rate was pioneered by Wright who the value, the stronger and more sudden is produced the first meter specifically the contraction of expiratory muscles of designed to measure this index of lung respiration. The peak expiratory flow is function. Since the original design was measured in ml/second. In an individual introduced in the late 1950s, a more whose lungs have not been affected by any portable, lower-cost‎ version,‎ the‎ ‘Mini- pathological condition, the factors affecting Wright’‎ peak‎ flow‎ meters‎ have‎ become‎ peak expiratory flow rate are the dimensions available these days across the world. of the large intra and extrathoracic airways, Certain softwares are also available for the [‎4] the force generated by the expiratory measurement of respiratory function. The muscles, the speed with which maximal clinical significance of airflow, volume and alveolar pressure is reached, [‎5] and how the pressure has been well documented in lung was stretched prior to the Peak research. The instrument Aerophone II expiratory flow rate manoeuvre. There is (Manufacturer: F.J. Electronics, Ellebuen 3 also research evidence that exercise training DK-290), offers a practical recording and increases the peak expiratory flow rate analysing system for airflow measurements. because of an increase in respiratory muscle It takes the advantage of a sophisticated strength. The Peak expiratory flow rate is an combination of a hardware transducer effort dependent parameter emerging from system with transducers recording the the large airways within about 100–120 ms aerodynamic signal, and a computerised data of the start of the forced expiration. [‎6] Peak processing. The aerophone II includes the flow rate is higher in physically fit or, measurements of respiratory parameters healthier population such as Armed forces (peak flow, vital capacity, forced 1 second personnel and Athletes. [‎7] expiration and duration), sustained Need for the study phonation parameters(minimum, maximum The measurement of peak expiratory and average sound pressure level, dynamic flow rate is useful in the clinical assessment range, volume of air used, mean flow rate, of airway obstruction. It is one of many tests phonation duration and quotient), speech that measure how well airways are parameters (sound pressure level, air functioning. Speech language pathologists pressure and airflow during running speech usually consider vital capacity as a sole and duration),voice parameters(voice range measure in the evaluation of respiratory profile), voice efficiency parametres function. The research focus on the peak (subglottal pressure, glottal resistance, airflow as an aerodynamic measure in Indian International Journal of Health Sciences & Research (www.ijhsr.org) 241 Vol.5; Issue: 2; February 2015 scenario is sparse. There have been no Manufacturer: F.J. Electronics, Ellebuen 3 reports of studies on peak expiratory flow DK-290, Denmark. rate for Indian population using Aerophone Procedure: The test procedure was II analyser. Hence, this investigation was explained to the participants and a undertaken with an objective of determining demonstration of maneuver was given to peak expiratory flow rate in Indian young each of them. The participants were asked to adults. remain in relaxed seated position. The The aim of the current study was to participants were asked to hold the peak study the peak flow as an aerodynamic flow meter horizontal to their mouth, take in measure in healthy individuals with a deep breath, make a tight seal with their objectives to study peak air flow rate lips around the mouth tube, and asked to measure range in young healthy adults, to blow out as hard and fast as they could in determine the effect of height, weight and one breath. They were requested to take a body mass index on peak air flow rate and to deep breath and exhale as forcefully as compare across the gender. possible in one single blow into the instrument. A short sharp breath was MATERIALS AND METHODS instructed rather than a prolonged forceful This study was conducted in a breath. Two satisfactory readings were taken multidisciplinary hospital and was approved and highest of the two was taken for further by the Institutional Ethical Committee. The analysis. The obtained data was analysed study followed a cross sectional design with with SPSS software. convenient sampling. Participants: The participants were divided RESULTS into 2 groups. Group 1 consisted of n=30 In the present study, peak airflow young males in the age range of 18- 22 was investigated in young males and years. Group 2 consisted of n=30 young females and was correlated with respect to females in the age range of 18 to 22 years. their height and weight. Descriptive The mean age of the male participants was statistics were employed to find out mean 21.3 (± 1.09) years and the mean age of the and standard deviation of peak airflow female participants was20.27 (±1.015) measure. It was observed that peak airflow years. All participants were free of was higher in females as compared to that of cardiovascular disease, diabetes, cancer, males. There was significant difference respiratory diseases, smoking and any observed between the two groups at surgery/ skeletal abnormality likely to affect p<0.001. In the present study, the lung functions. The anthropometric participants were divided into 2 groups for measurements such as height, weight and height (140-165 centimeters; 166- Body Mass Index (BMI) was calculated for 190centimetres) and weight (40-70 all the participants. Body Mass Index
Recommended publications
  • Maximum Expiratory Flow Rates in Induced Bronchoconstriction in Man

    Maximum Expiratory Flow Rates in Induced Bronchoconstriction in Man

    Maximum expiratory flow rates in induced bronchoconstriction in man A. Bouhuys, … , B. M. Kim, A. Zapletal J Clin Invest. 1969;48(6):1159-1168. https://doi.org/10.1172/JCI106073. Research Article We evaluated changes of maximum expiratory flow-volume (MEFV) curves and of partial expiratory flow-volume (PEFV) curves caused by bronchoconstrictor drugs and dust, and compared these to the reverse changes induced by a bronchodilator drug in previously bronchoconstricted subjects. Measurements of maximum flow at constant lung inflation (i.e. liters thoracic gas volume) showed larger changes, both after constriction and after dilation, than measurements of peak expiratory flow rate, 1 sec forced expiratory volume and the slope of the effort-independent portion of MEFV curves. Changes of flow rates on PEFV curves (made after inspiration to mid-vital capacity) were usually larger than those of flow rates on MEFV curves (made after inspiration to total lung capacity). The decreased maximum flow rates after constrictor agents are not caused by changes in lung static recoil force and are attributed to narrowing of small airways, i.e., airways which are uncompressed during forced expirations. Changes of maximum expiratory flow rates at constant lung inflation (e.g. 60% of the control total lung capacity) provide an objective and sensitive measurement of changes in airway caliber which remains valid if total lung capacity is altered during treatment. Find the latest version: https://jci.me/106073/pdf Maximum Expiratory Flow Rates in Induced Bronchoconstriction in Man A. Bouiuys, V. R. HuNTr, B. M. Kim, and A. ZAPLETAL From the John B. Pierce Foundation Laboratory and the Yale University School of Medicine, New Haven, Connecticut 06510 A B S T R A C T We evaluated changes of maximum ex- rates are best studied as a function of lung volume.
  • Spirometry Basics

    Spirometry Basics

    SPIROMETRY BASICS ROSEMARY STINSON MSN, CRNP THE CHILDREN’S HOSPITAL OF PHILADELPHIA DIVISION OF ALLERGY AND IMMUNOLOGY PORTABLE COMPUTERIZED SPIROMETRY WITH BUILT IN INCENTIVES WHAT IS SPIROMETRY? Use to obtain objective measures of lung function Physiological test that measures how an individual inhales or exhales volume of air Primary signal measured–volume or flow Essentially measures airflow into and out of the lungs Invaluable screening tool for respiratory health compared to BP screening CV health Gold standard for diagnosing and measuring airway obstruction. ATS, 2005 SPIROMETRY AND ASTHMA At initial assessment After treatment initiated and symptoms and PEF have stabilized During periods of progressive or prolonged asthma control At least every 1-2 years: more frequently depending on response to therapy WHY NECESSARY? o To evaluate symptoms, signs or abnormal laboratory tests o To measure the effect of disease on pulmonary function o To screen individuals at risk of having pulmonary disease o To assess pre-operative risk o To assess prognosis o To assess health status before beginning strenuous physical activity programs ATS, 2005 SPIROMETRY VERSUS PEAK FLOW Recommended over peak flow meter measurements in clinician’s office. Variability in predicted PEF reference values. Many different brands PEF meters. Peak Flow is NOT a diagnostic tool. Helpful for monitoring control. EPR 3, 2007 WHY MEASURE? o Some patients are “poor perceivers.” o Perception of obstruction variable and spirometry reveals obstruction more severe. o Family members “underestimate” severity of symptoms. o Objective assessment of degree of airflow obstruction. o Pulmonary function measures don’t always correlate with symptoms. o Comprehensive assessment of asthma.
  • Association of Cystic Fibrosis Withallergy

    Association of Cystic Fibrosis Withallergy

    Arch Dis Child: first published as 10.1136/adc.51.7.507 on 1 July 1976. Downloaded from Archives of Disease in Childhood, 1976, 51, 507. Association of cystic fibrosis with allergy J. 0. WARNER, B. W. TAYLOR, A. P. NORMAN, and J. F. SOOTHILL From the Hospital for Sick Children, London Warner, J. O., Taylor, B. W., Norman, A. P., and Soothill, J. F. (1976). Archives of Disease in Childhood, 51, 507. Association of cystic fibrosis with allergy. Immediate skin hypersensitivity to various inhalant allergens was present in 59°% of 123 children with cystic fibrosis (CF), a much higher percentage than in the general population. This is consistent with the idea that atopy arises as a result of impaired handling of antigen at mucosal surfaces. The allergic CF children had more chest infections, a worse chest x-ray appearance, and lower peak expiratory flow rates. Allergic diseases were also frequent in the CF obligate heterozygotes (32% of mothers and 26 % of fathers). It is suggested that the heterozygotes may also have a mucosal abnormality resulting in defective antigen handling. The suggestion that atopy may result from exces- TABLE I sive stimulation of the IgE-producing cells because Clinical presentation of 123 children at initial of failure of antigen exclusion at mucosal surfaces diagnosis of cystic fibrosis related to subsequent skin- is supported by the observation that much infantile test findings atopy is preceded by IgA deficiency (Taylor et al., 1973). This is consistent with the view that anti- Skin test gen exclusion is, in part, dependent on immune Presentation Total reactions.
  • Asthma Guidelines

    Asthma Guidelines

    ASTHMA CLINICAL PRACTICE GUIDELINES INITIAL CARE Assess ABCs Consider Alternative Diagnoses ■ Airway ■ Bronchiolitis (especially under age 2) ■ Breathing ■ Pneumonia ■ Circulation ■ Foreign body ■ Cardiac disease or congestive heart failure Initial Triage Options ■ Congenital airway abnormalities ■ Emergency Department or Outpatient Management ■ Immune deficiency/mucociliary defect ■ Admission to Inpatient Unit ■ Cystic fibrosis ■ Stabilize and transfer emergently to PICU based on clinical judgment and factors such as: Asthma: • Intubation, or severe compromise in patient previously ■ Episodic symptoms of airflow obstruction including intubated for asthma wheezing, cough, or chest tightness • Worsening on maximal medical therapy ■ Airflow obstruction at least partially reversible • Evidence for impending respiratory failure ■ Exclusion of alternative diagnoses • Complex co-existing or co-morbid conditions EXCLUSION CRITERIA ■ Age under 2 years ■ Alternative diagnosis (see above) ■ Severe distress or requiring PICU Care ASTHMA EXACERBATION CLASSIFICATION Mild Exacerbation Severe Exacerbation ■ Patient is alert and oriented, speaks in sentences, no ■ Patient is breathless at rest, speaks in words. Patient is using accessory muscle use, may have slight expiratory wheeze, accessory muscles, has suprasternal retractions, may have and is tachypneic. loud wheezing (throughout inhalation and exhalation), and ■ Peak flow >80% of predicted or personal best is tachypneic. (see background information for age norms) ■ Peak flow <50 % of predicted
  • BSL Lesson 13

    BSL Lesson 13

    Physiology Lessons Lesson 13 for use with the PULMONARY FUNCTION II Biopac Student Lab Pulmonary Flow Rates Forced Expiratory Volume (FEV1,2,3) PC under Windows 95/98/NT 4.0/2000 Maximal Voluntary Ventilation (MVV) or Macintosh Manual Revision 12132000.PL3.6.6-ML3.0.7 Number of cycles in 12 second interval Average Volume Richard Pflanzer, Ph.D. per cycle Associate Professor Indiana University School of Medicine Purdue University School of Science J.C. Uyehara, Ph.D. Biologist Number of cycles/minute = Number of cycles in 12 second interval X 5 MVV = (Average volume per cycle) X (Number of cycles per minute) BIOPAC Systems, Inc. William McMullen Vice President BIOPAC Systems, Inc. BIOPAC Systems, Inc. 42 Aero Camino, Santa Barbara, CA 93117 (805) 685-0066, Fax (805) 685-0067 Email: [email protected] Web Site: http://www.biopac.com Page 2 Lesson 13: Pulmonary Function II Biopac Student Lab V3.0 I. INTRODUCTION The respiratory or pulmonary system performs the important functions of supplying oxygen (O2) during inhalation, removing carbon dioxide (CO2) during exhalation, and adjusting the acid-base balance (pH) of the body by removing acid-forming CO2. Because oxygen is necessary for cellular metabolism, the amount of air that the pulmonary system provides is important in setting the upper limits on work capacities or metabolism. Therefore, the measurement of lung volumes and the rate of air movement (airflow) are important tools in assessing the health and capacities of a person. In this lesson, you will measure: Forced Vital Capacity (FVC), which is the maximal amount of air that a person can forcibly exhale after a maximal inhalation.
  • Restrictive Lung Disease

    Restrictive Lung Disease

    Downloaded from https://academic.oup.com/ptj/article/48/5/455/4638136 by guest on 29 September 2021 RESTRICTIVE LUNG DISEASE WARREN M. GOLD, M.D. RESTRICTIVE LUNG DISEASE is a These disorders can be divided into two pattern of abnormal lung function defined by groups: extrapulmonary and pulmonary. a decrease in lung volume (Fig. I).1,2 The In extrapulmonary restriction, an abnormal total lung capacity is decreased and, in severe increase in the stiffness of the chest wall (kypho­ restrictive defects, all of the subdivisions of the scoliosis) restricts the lung volumes, as does total lung capacity including vital capacity, respiratory muscle weakness (poliomyelitis or functional residual capacity, and residual vol­ muscular dystrophy). These extrapulmonary ume are decreased. In mild or moderately se­ causes of pulmonary restriction are treated vere restrictive defects, the residual volume may be normal or slightly increased. CLINICAL DISORDERS CAUSING TABLE 1 RESTRICTIVE LUNG DISEASE CAUSES OF RESTRICTIVE LUNG DISEASE Restrictive lung disease is not a specific clin­ I. Extrapulmonary restriction 3 ical entity, but only one of several patterns of A. Chest wall stiffness (kyphoscoliosis) B. Respiratory-muscle weakness (muscular dystrophy)4 abnormal lung function. It is produced by a C. Pleural disease (pneumothorax)5 number of clinical disorders (see Table 1). II. Pulmonary restriction A. Surgical resection (pneumonectomy)6.7 Dr. Gold: Director, Pulmonary Laboratory and Re­ B. Tumor (bronchogenic carcinoma or metastatic tumor)8 search Associate in Cardiology (Pulmonary Physiology), C. Heart disease (hypertensive, arteriosclerotic, rheu­ Children's Hospital Medical Center; Associate in Pedi­ matic, congenital)9 atrics and Tutor in Medical Science, Harvard Medical 10 11 School, Boston, Massachusetts.
  • Peak Flow Monitoring Page 1 of 3

    Peak Flow Monitoring Page 1 of 3

    UTMB RESPIRATORY CARE SERVICES Policy 7.3.14 PROCEDURE - Peak Flow Monitoring Page 1 of 3 Peak Flow Monitoring Effective: 10/19/94 Formulated: 05/93 Revised: 04/04/18 Peak Flow Monitoring Purpose To quantify the efficacy of bronchodilator therapy in patients with limited or restricted expiratory flow rates. Scope Accountability/Special Training May be administered by a Licensed Respiratory Care Practitioner. Training must be equivalent to the minimal Therapist entry level in Respiratory Care Services with age specific recognition of requirements of population treated. Physician's A physician's order is required for peak flow meter measurements Order Peak flow monitoring is an integral part of bronchodilator therapy when ordered by a physician Indications Patients with limited or severely restricted expiratory flow. Patients on Bronchodilator Therapy. Patient is able to understand and physically able to attempt the test. Goals To monitor progression of the patients condition. Monitor drug efficacy. Improve dosing accuracy of MDI/Bronchodilator therapy. Contra- Patient does not have a level of comprehension that enables them to do indications the test. Patient will not cooperate. Patient has a facial condition or neurological condition that alters their ability to do the test. Patient distress level is such that attempting would only deteriorate their condition. Equipment Peak flow meter Procedure Step Action 1 Check physician's orders. 2 Obtains peak flow device. 3 Wash hands thoroughly. 4 Verifies patient by two identifiers 5 Explain Peak Flow monitoring to patient. Continued next page UTMB RESPIRATORY CARE SERVICES Policy 7.3.14 PROCEDURE - Peak Flow Monitoring Page 2 of 3 Peak Flow Monitoring Effective: 10/19/94 Formulated: 05/93 Revised: 04/04/18 Procedure Continued 6 Make sure the indicator is at the bottom of the scale.
  • NIOSH), Centers for Disease Control and Prevention (CDC)

    NIOSH), Centers for Disease Control and Prevention (CDC)

    Technical Report Filtering Facepiece Respirators with an Exhalation Valve: Measurements of Filtration Efficiency to Evaluate Their Potential for Source Control Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Technical Report Filtering Facepiece Respirators with an Exhalation Valve: Measurements of Filtration Efficiency to Evaluate Their Potential for Source Control DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health National Personal Protective Technology Laboratory This document is in the public domain and may be freely copied or reprinted. Disclaimer Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). In addition, citations to websites external to NIOSH do not constitute NIOSH endorsement of the sponsoring organizations or their programs or products. Furthermore, NIOSH is not responsible for the content of these websites. All web addresses referenced in this document were accessible as of the publication date. Get More Information Find NIOSH products and get answers to workplace safety and health questions: 1-800-CDC-INFO (1-800-232-4636) | TTY: 1-888-232-6348 CDC/NIOSH INFO: cdc.gov/info | cdc.gov/niosh Monthly NIOSH eNews: cdc.gov/niosh/eNews Suggested Citation NIOSH [2020]. Filtering facepiece respirators with an exhalation valve: measurements of filtration efficiency to evaluate their potential for source control. By Portnoff L, Schall J, Brannen J, Suhon N, Strickland K, Meyers J. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No.
  • Physical and Geometric Constraints Shape the Labyrinth-Like Nasal Cavity

    Physical and Geometric Constraints Shape the Labyrinth-Like Nasal Cavity

    Physical and geometric constraints shape the labyrinth-like nasal cavity David Zwickera,b,1, Rodolfo Ostilla-Monico´ a,b, Daniel E. Liebermanc, and Michael P. Brennera,b aJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138; bKavli Institute for Bionano Science and Technology, Harvard University, Cambridge, MA 02138; and cDepartment of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138 Edited by Leslie Greengard, New York University, New York, NY, and approved January 26, 2018 (received for review August 29, 2017) The nasal cavity is a vital component of the respiratory system take into account geometric constraints imposed by the shape that heats and humidifies inhaled air in all vertebrates. Despite of the head that determine the length of the nasal cavity, its this common function, the shapes of nasal cavities vary widely cross-sectional area, and, generally, the shape of the space that it across animals. To understand this variability, we here connect occupies. To tackle this complex problem, we first show that, nasal geometry to its function by theoretically studying the air- without geometric constraints, optimal shapes have slender flow and the associated scalar exchange that describes heating cross-sections. We then demonstrate that these shapes can be and humidification. We find that optimal geometries, which have compacted into the typical labyrinth-like shapes without much minimal resistance for a given exchange efficiency, have a con- loss in performance. stant gap width between their side walls, while their overall shape can adhere to the geometric constraints imposed by the Results head. Our theory explains the geometric variations of natural The Flow in the Nasal Cavity Is Laminar.
  • Standardisation of Spirometry

    Standardisation of Spirometry

    Eur Respir J 2005; 26: 319–338 DOI: 10.1183/09031936.05.00034805 CopyrightßERS Journals Ltd 2005 SERIES ‘‘ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING’’ Edited by V. Brusasco, R. Crapo and G. Viegi Number 2 in this Series Standardisation of spirometry M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P.M. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi and J. Wanger CONTENTS AFFILIATIONS Background ............................................................... 320 For affiliations, please see Acknowledgements section FEV1 and FVC manoeuvre .................................................... 321 Definitions . 321 CORRESPONDENCE Equipment . 321 V. Brusasco Requirements . 321 Internal Medicine University of Genoa Display . 321 V.le Benedetto XV, 6 Validation . 322 I-16132 Genova Quality control . 322 Italy Quality control for volume-measuring devices . 322 Fax: 39 103537690 E-mail: [email protected] Quality control for flow-measuring devices . 323 Test procedure . 323 Received: Within-manoeuvre evaluation . 324 March 23 2005 Start of test criteria. 324 Accepted after revision: April 05 2005 End of test criteria . 324 Additional criteria . 324 Summary of acceptable blow criteria . 325 Between-manoeuvre evaluation . 325 Manoeuvre repeatability . 325 Maximum number of manoeuvres . 326 Test result selection . 326 Other derived indices . 326 FEVt .................................................................. 326 Standardisation of FEV1 for expired volume, FEV1/FVC and FEV1/VC.................... 326 FEF25–75% .............................................................. 326 PEF.................................................................. 326 Maximal expiratory flow–volume loops . 326 Definitions. 326 Equipment . 327 Test procedure . 327 Within- and between-manoeuvre evaluation . 327 Flow–volume loop examples. 327 Reversibility testing . 327 Method .
  • Influence of Inhalation/Exhalation Ratio and of Respiratory

    Influence of Inhalation/Exhalation Ratio and of Respiratory

    sustainability Article Slow-Paced Breathing: Influence of Inhalation/Exhalation Ratio and of Respiratory Pauses on Cardiac Vagal Activity Sylvain Laborde 1,2,* , Maša Iskra 1, Nina Zammit 1, Uirassu Borges 1,3, Min You 4, Caroline Sevoz-Couche 5 and Fabrice Dosseville 6,7 1 Department of Performance Psychology, Institute of Psychology, German Sport University Cologne, Cologne 50933, Germany; [email protected] (M.I.); [email protected] (N.Z.) 2 UFR STAPS, EA 4260 CESAMS, Normandie Université, 14000 Caen, France 3 Department of Health & Social Psychology, Institute of Psychology, German Sport University Cologne, 50933 Cologne, Germany; [email protected] 4 UFR Psychologie, EA3918 CERREV, Normandie Université, 14000 Caen, France; [email protected] 5 INSERM, Unité Mixte de Recherche (UMR) S1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, 75000 Paris, France; [email protected] 6 UMR-S 1075 COMETE, Normandie Université, 14000 Caen, France 7 INSERM, UMR-S 1075 COMETE, 14000 Caen, France; [email protected] * Correspondence: [email protected]; Tel.: +49-221-49-82-57-01 Abstract: Slow-paced breathing has been shown to enhance the self-regulation abilities of athletes via its influence on cardiac vagal activity. However, the role of certain respiratory parameters (i.e., inhalation/exhalation ratio and presence of a respiratory pause between respiratory phases) still needs to be clarified. The aim of this experiment was to investigate the influence of these respiratory Citation: Laborde, S.; Iskra, M.; parameters on the effects of slow-paced breathing on cardiac vagal activity. A total of 64 athletes Zammit, N.; Borges, U.; You, M.; (27 female; Mage = 22, age range = 18–30 years old) participated in a within-subject experimental Sevoz-Couche, C.; Dosseville, F.
  • Normative Data of Peak Expiratory Flow Rate in Healthy School Children Of

    Normative Data of Peak Expiratory Flow Rate in Healthy School Children Of

    Research Article Normative data of peak expiratory flow rate in healthy school children of Ghaziabad city—a pilot study Rinku Garg1, Sharmila Anand2, Ravi Kant Sehgal3, Hari Pal Singh3 1Department of Physiology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India. 2Department of Pharmacology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India. 3Department of Community Medicine, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India. Correspondence to: Rinku Garg, E-mail: [email protected] Received March 6, 2015. Accepted May 12, 2015 || ABSTRACT Background: Age, sex, weight, and height are the main factors that affect peak expiratory flow rate (PEFR). Various authors have shown that geographical, climatic, anthropometric, nutritional, and socioeconomic conditions of India are associated with regional differences in lung function. Aims and Objective: To establish the normative data of PEFR among school children aged 10–14 years in Ghaziabad city, Uttar Pradesh, India. Materials and Methods: A cross-sectional study was done in 500 school children aged 10–14 years in Ghaziabad city. PEFR was recorded with the Mini-Wright Peak Flow Meter. Anthropometric variables such as age, height, weight, and body mass index were recorded. Results were analyzed by ANOVA with SPSS, version 17.0, using unpaired t test. Result: Results showed that there was an increase in PEFR in boys and girls with an increase in age, height, and weight. Conclusion: Normative data of this study can be useful for the